_________________
July 29, 2025 | Avance Clinical enhances trial integrity and efficiency with ValGenesis' digital validation platform, ensuring compliance and operational excellence in global clinical trials.
ValGenesis secures $16 million in strategic financing to drive global expansion and AI innovation in digital validation solutions for life sciences.
ValGenesis and CAI partner to enhance AI-enabled digital validation in life sciences, modernizing processes, reducing manual effort, and improving compliance outcomes.
ValGenesis launches the first AI-enabled platform, Smart GxP, to unify validation and process development, enhancing efficiency and compliance in the life sciences sector.
Scigeniq modernizes its processes with a swift 3-month implementation of ValGenesis VLMS, enhancing efficiency and compliance in digital validation.
Discover ValGenesis' AI-enabled digital validation assistant, VAL, set to revolutionize speed, efficiency, and compliance in life sciences at INTERPHEX 2025.
Global pharma leader digitizes entire cleaning validation lifecycle with ValGenesis iClean, enhancing efficiency, compliance, and innovation across its global operations.
Major U.S. healthcare provider selects ValGenesis VLMS to streamline validation, achieve FDA compliance, and enhance operational efficiency across its network of medical institutions.
ValGenesis and Hitachi Industry & Control Solutions partner to enhance digital validation for Japan's life sciences, accelerating drug development and regulatory compliance.
ValGenesis and Compliance Group partner to accelerate digital validation and regulatory compliance in life sciences, enhancing quality excellence and operational efficiency.